Please use this identifier to cite or link to this item:
Title: Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance.
Authors: Jiménez-Pérez, Miguel
González-Grande, Rocío
España Contreras, Pilar
Pinazo Martínez, Isabel
de la Cruz Lombardo, Jesús
Olmedo Martín, Raúl
Keywords: Direct-acting antivirals;Hepatitis C virus;Resistance;Treatment
metadata.dc.subject.mesh: Antiviral Agents
Drug Resistance, Viral
Hepatitis C, Chronic
Treatment Failure
Viral Nonstructural Proteins
Issue Date: 2016
Abstract: The use of direct-acting antivirals (DAAs) to treat chronic hepatitis C has resulted in a significant increase in rates of sustained viral response (around 90%-95%) as compared with the standard treatment of peginterferon/ribavirin. Despite this, however, the rates of therapeutic failure in daily clinical practice range from 10%-15%. Most of these cases are due to the presence of resistant viral variants, resulting from mutations produced by substitutions of amino acids in the viral target protein that reduce viral sensitivity to DAAs, thus limiting the efficacy of these drugs. The high genetic diversity of hepatitis C virus has resulted in the existence of resistance-associated variants (RAVs), sometimes even before starting treatment with DAAs, though generally at low levels. These pre-existing RAVs do not appear to impact on the sustained viral response, whereas those that appear after DAA therapy could well be determinant in virological failure with future treatments. As well as the presence of RAVs, virological failure to treatment with DAAs is generally associated with other factors related with a poor response, such as the degree of fibrosis, the response to previous therapy, the viral load or the viral genotype. Nonetheless, viral breakthrough and relapse can still occur in the absence of detectable RAVs and after the use of highly effective DAAs, so that the true clinical impact of the presence of RAVs in therapeutic failure remains to be determined.
metadata.dc.identifier.doi: 10.3748/wjg.v22.i29.6573
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons